abstract |
The present invention relates to compounds of formula (I). Formula I The compounds according to the invention bind to CB2 receptors and are agonists, antagonists or inverse agonists of said CB2 receptors and are useful for treating inflammation. These compounds that are agonists are further useful in treating pain. |